|
|
|
| Pharmaceutical Mergers and Acquisitions |
|
| Table of Contents Published: 2009/10 |
| Pharmaceutical Mergers and Acquisitions guides you to build an M&A plan that focuses on key goals, avoids costly mistakes, and realizes deal potential as quickly as possible. CEI designed this study to identify the primary drivers of M&A activity. Through ... |
| Autoimmune Market Forecast to 2014 |
|
| Table of Contents Published: 2009/06 |
| From sales projections to clinical trial data to analysts' insights, Autoimmune Market Forecast to 2014 tells you everything you need to know. Unlike other market forecast reports out there, ours covers all of the major indications - rheumatoid arthritis, ... |
| Managing Clinical Investigator Compensation |
|
| Table of Contents Published: 2009/05 |
| The pharmaceutical industry' s commercial relationships with physicians and thought leaders have fallen under intense scrutiny. The OIG, Congress, state legislatures and consumer advocacy groups have all recently decried what they view as unethically and ... |
| Reinventing Pharmaceutical Sales Forces |
|
| Table of Contents Published: 2009/04 |
| The more is better methodology of selling is dead. The Wall Street Journal now predicts that the number of pharmaceutical sales reps in the US will drop to 70,000 by the year 2015. This is a tremendous change from the boom of the 1990s and early 2000s, wh ... |
| The Toolkit for Diabetes MSL Programs |
|
| Table of Contents Published: 2009/03 |
| Currently, about 246 million people worldwide have diabetes; this number is expected to increase to 380 million by 2025, according to the International Diabetes Foundation. Such staggering figures solidify diabetes' position as a primary therapeutic area. ... |
| Diabetes Market Forecast to 2013 |
|
| Table of Contents Published: 2008/11 |
| CEI' s veteran analysts answer these questions - and more - by placing critical drug information in a relevant industry-wide context. Other reports skim the surface, examining only top drugs at top companies. Ours is complete, covering marketed brands, pi ... |
| Improve Market Research Impact |
|
| Table of Contents Published: 2008/11 |
| Tightening markets, generic encroachment, slowing revenue streams and frequent clinical failures have left pharmaceutical companies treading carefully in efforts to find the next profitable drug. Companies are now trying to determine the correct markets t ... |
| Pharmaceutical Alliance Management |
|
| Table of Contents Published: 2008/09 |
| Nearly half of today' s top-selling drugs were the result of partnerships. Companies across the industry annually spend hundreds of millions of dollars to utilize other firms' discovery, development and marketing capabilities in their quests for the next ... |
| Streamlining Clinical Trials |
|
| Table of Contents Published: 2008/08 |
| Research shows that there is much room for improvement. The average Phase 1, 2, and 3 trials exceed their timelines by 20%. Delays in the clinical trial process cost pharma companies hundreds of thousands - even millions - in sales. Today, companies also ... |
| The Evolving Global Meeting Management Strategy |
|
| Table of Contents Published: 2008/07 |
| This study culminates a yearlong collaboration between Cutting Edge Information, Medical Meetings magazine and the Center for Business Intelligence. The report reveals critical trends across the pharmaceutical, biotech, and medical device industries. ... |
| The Oncology Market Forecast to 2013 |
|
| Table of Contents Published: 2008/07 |
| Our experienced analysts have reviewed thousands of historical and forecasted data points to provide the most comprehensive oncology market outlook ever - pulling together data from our own proprietary PharmaEdge databases, along with hundreds of addition ... |
| Medical Affairs: Delivering Strategic Value |
|
| Table of Contents Published: 2008/04 |
| Medical affairs plays an instrumental role in providing medical and scientific perspectives for a company' s brands. While the function has long been considered vital, recent years have brought tremendous change. Pressure to remain compliant and increasin ... |
|
 Top
|
|
View Cart
